SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jenks Timothy Storrs

(Last)

(First)

(Middle)

2911 ZANKER ROAD

(Street)

SAN JOSE

94134

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2011

3. Issuer Name and Ticker or Trading Symbol
NEOPHOTONICS CORP [ NPTN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, CEO and Chairman

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,133	D
Common Stock	8,500	I	See Footnote⁽¹⁾
Common Stock	6,000	I	See Footnote⁽²⁾
Common Stock	393	I	See Footnote⁽³⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series 1 Preferred Stock	⁽⁴⁾	⁽⁴⁾	Common Stock	191	⁽⁴⁾	D
Series 3 Preferred Stock	⁽⁵⁾	⁽⁵⁾	Common Stock	60	⁽⁵⁾	D
Series X Preferred Stock	⁽⁶⁾	⁽⁶⁾	Common Stock	480	⁽⁶⁾	D
Series 2 Preferred Stock	⁽¹²⁾	⁽¹²⁾	Common Stock	445	⁽¹²⁾	I	See Footnote⁽³⁾
Series 3 Preferred Stock	⁽⁵⁾	⁽⁵⁾	Common Stock	200	⁽⁵⁾	I	See Footnote⁽³⁾
Series X Preferred Stock	⁽⁶⁾	⁽⁶⁾	Common Stock	1,760	⁽⁶⁾	I	See Footnote⁽³⁾
Stock Option (right to buy)	⁽⁷⁾	05/10/2014	Common Stock	79,999	$3.75	D
Stock Option (right to buy)	⁽⁷⁾	07/06/2015	Common Stock	20,146	$4.6472	D
Stock Option (right to buy)	⁽⁷⁾	05/15/2017	Common Stock	193,019	$4.25	D
Stock Option (right to buy)	⁽⁷⁾	05/14/2018	Common Stock	1,286	$4.25	D
Stock Option (right to buy)	⁽⁸⁾	11/03/2018	Common Stock	51,286	$4.25	D
Stock Option (right to buy)	⁽⁹⁾	05/27/2019	Common Stock	31,999	$4.25	D
Stock Option (right to buy)	⁽¹¹⁾	01/26/2020	Common Stock	16,799	$12	D
Stock Option (right to buy)	⁽¹⁰⁾	12/12/2020	Common Stock	18,000	$7.5	D

Explanation of Responses:

1. Represents shares held in trust by the Reporting Person as custodian for his minor child, Hana C. Jenks.

2. Represents shares held in trust by the Reporting Person as custodian for his minor child, Saya J. Jenks.

3. Represents shares held by the Timothy S. Jenks and Atsuko K. Jenks Declaration of Trust dated January 7, 1996.

4. Each share of Issuer's Series 1 Preferred Stock will automatically convert into one share of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and has no expiration date.

5. Each share of Issuer's Series 3 Preferred Stock will automatically convert into one share of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and has no expiration date.

6. Each share of Issuer's Series X Preferred Stock will automatically convert into 400 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and has no expiration date.

7. 100% of the shares subject to the option are vested and exercisable.

8. Shares shall vest at a rate of 1/48th of the total number of option shares on each monthly anniversary of the vesting commencement date (08/01/2008), so long as the Reporting Person remains an employee of or consultant to the Issuer or its qualifying subsidiaries. This grant is early exercisable.

9. 25% of the option shares shall vest on the one-year anniversary of the vesting commencement date (05/01/2009), and 1/48th of the total number of option shares shall vest on each monthly anniversary thereafter, so long as the Reporting Person remains an employee of or consultant to the Issuer or its qualifying subsidiaries. This grant is early exercisable.

10. 25% of the option shares shall vest on the one-year anniversary of the vesting commencement date (12/01/2010), and 1/48th of the total number of option shares shall vest on each monthly anniversary thereafter, so long as the Reporting Person remains an employee of or consultant to the Issuer or its qualifying subsidiaries. This grant is early exercisable.

11. 50% of the option shares shall vest on the two-year anniversary of the vesting commencement date (01/27/2010), and 1/48th of the total number of option shares shall vest on each monthly anniversary thereafter, so long as the Reporting Person remains an employee of or consultant to the Issuer or its qualifying subsidiaries.

12. Each share of Issuer's Series 2 Preferred Stock will automatically convert into one share of the Issuer's Common Stock upon the closing of the Issuer's initial public offering and has no expiration date.

	/s/ Timothy S. Jenks by Erin Williams, Attorney-in-Fact	02/01/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.